Ji et al reported the Gastric Cancer Peritoneal Carcinomatosis Risk Score for predicting the prognosis of a patient with peritoneal carcinomatosis associated with gastric cancer. The authors are from Loma Linda University.
Patient selection: peritoneal carcinomatosis associated with gastric cancer, >= 18 years of age
Parameters:
(1) age of the patient in years
(2) race/ethnicity
(3) clinical T stage
(4) histologic type
(5) tumor location in stomach
(6) histologic grade
Parameter |
Finding |
Points |
age of the patient |
18 to 39 years |
6 |
|
40 to 59 years |
3 |
|
>= 60 years |
0 |
race/ethnicity |
non-Hispanic white |
0 |
|
Asian or other |
0.5 |
|
non-Hispanic black |
3 |
|
Hispanic |
2.5 |
clinical T stage |
T1 |
0 |
|
T2 ot T3 |
1 |
|
T4 |
5.5 |
histologic type |
intestinal |
0 |
|
NOS |
1 |
|
mucinous |
1.5 |
|
diffuse |
2.5 |
|
signet ring cell |
3.5 |
tumor location |
proximal |
0 |
|
body |
2.5 |
|
distal |
2.5 |
|
overlapping |
4 |
histologic grade |
well-differentiated |
0 |
|
moderately differentiated |
2 |
|
poorly differentiated |
4 |
|
undifferentiated |
4 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 26
Total Score |
Percent with Peritoneal Carcinomatosis |
0 to 10 |
3.2% |
10.5 to 14 |
10% |
14.5 to 17 |
15% |
17.5 to 20 |
26% |
> 20 |
46% |
Performance:
• The area under the ROC curve is 0.82.
Specialty: Hematology Oncology